OverviewSuggest Edit

ResMed develops, manufactures and distributes medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. It offers a number of products for sleep-disordered breathing and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. 

TypePublic
Founded1989
HQSan Diego, CA, US
Websiteresmed.com
Employee Ratings4
Overall CultureA+

Latest Updates

Employees (est.) (Jun 2019)7,240(+22%)
Job Openings358
Revenue (FY, 2020)$3 B(+14%)
Share Price (Jun 2021)$218.6
Cybersecurity ratingCMore

Key People/Management at ResMed

Michael Mick Farrell

Michael Mick Farrell

CEO
Rob Douglas

Rob Douglas

President and Chief Operating Officer
David Pendarvis

David Pendarvis

Chief Administrative Officer, Global General Counsel
Jim Hollingshead

Jim Hollingshead

President, Sleep Business
McHale Richie

McHale Richie

Chief Transformation Officer
Raj Sodhi

Raj Sodhi

President, SaaS Business
Show more

ResMed Office Locations

ResMed has offices in San Diego, Alexandria, Rochester, Bella Vista and in 24 other locations
San Diego, CA, US (HQ)
9001 Spectrum Center Blvd
Alexandria, VA, US
Alexandria, VA, USA
Rochester, NY, US
1200 Brooks Ave
Bella Vista, AU
1 Elizabeth Macarthur Dr
Kontich, BE
50 Grote Steenweg
Beijing, CN
24 Dong San Huan Zhong Lu
Show all (28)

ResMed Financials and Metrics

ResMed Revenue

Embed Graph
View revenue for all periods
ResMed's revenue was reported to be $2.96 b in FY, 2020
USD

Revenue (Q3, 2021)

768.8m

Gross profit (Q3, 2021)

447.3m

Gross profit margin (Q3, 2021), %

58.2%

Net income (Q3, 2021)

(78.5m)

EBIT (Q3, 2021)

223.4m

Market capitalization (11-Jun-2021)

31.8b

Closing stock price (11-Jun-2021)

218.6

Cash (31-Mar-2021)

230.6m

EV

32.3b
ResMed's current market capitalization is $31.8 b.
USDQ1, 2011

Financial Leverage

1.2 x
Show all financial metrics

ResMed Acquisitions / Subsidiaries

Company NameDateDeal Size
Propeller HealthDecember 07, 2018
MatrixCare IncNovember 05, 2018$750 m

ResMed Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

ResMed Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

ResMed Online and Social Media Presence

Embed Graph

ResMed Company Culture

  • Overall Culture

    A+

    82/100

  • CEO Rating

    A+

    95/100

  • Compensation

    A+

    90/100

  • Diversity

    B

    70/100

Learn more on Comparably

ResMed News and Updates

Thinking about trading options or stock in Cassava Sciences, GameStop, Adobe, ResMed, or Pfizer?

NEW YORK, June 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, GME, ADBE, RMD, and PFE. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

ResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference

SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, beginning at approximate…

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021

- Year-over-year operating profit up 3%, non-GAAP operating profit up 2%

ResMed Announces Participation in the 23rd Annual Macquarie Australia Conference

SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Wednesday, May 5, 2021, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time) via …

Pulmonary Devices Market To Witness Huge Growth By 2027 with CAGR of 10.3% | ResMed, Masimo, Invacare Corporation, Koninklijke Philips N.V., Getinge AB

The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019. The market is anticipated to grow at a CAGR of 10.3% during 2019–2027. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Adult Ventilators Market Report 2020 Top Companies- Philips Healthcare, ResMed, Medtronic, Becton, Dickinson, Getinge, Dräger and more...

A new market study, titled “Global Adult Ventilators Market Professional Survey Report 2020”, has been featured on WiseGuyReports. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

ResMed Frequently Asked Questions

  • When was ResMed founded?

    ResMed was founded in 1989.

  • Who are ResMed key executives?

    ResMed's key executives are Michael Mick Farrell, Rob Douglas and David Pendarvis.

  • How many employees does ResMed have?

    ResMed has 7,240 employees.

  • What is ResMed revenue?

    Latest ResMed annual revenue is $3 b.

  • What is ResMed revenue per employee?

    Latest ResMed revenue per employee is $408.4 k.

  • Who are ResMed competitors?

    Competitors of ResMed include Dentsply Sirona, Leica Microsystems and MED-EL.

  • Where is ResMed headquarters?

    ResMed headquarters is located at 9001 Spectrum Center Blvd, San Diego.

  • Where are ResMed offices?

    ResMed has offices in San Diego, Alexandria, Rochester, Bella Vista and in 24 other locations.

  • How many offices does ResMed have?

    ResMed has 28 offices.